Krisztina Valter Selected Research

Central Nervous System Diseases (CNS Diseases)

10/2014

Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krisztina Valter Research Topics

Disease

13	Retinal Degeneration 01/2020 - 06/2011
8	Inflammation (Inflammations) 01/2018 - 01/2015
7	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 07/2010
7	Hyperoxia 10/2013 - 07/2005
3	Retinal Dystrophies 01/2017 - 10/2008
3	Retinal Diseases 01/2015 - 01/2014
2	Ganglion Cysts (Ganglion) 01/2020 - 05/2005
2	Soft Tissue Injuries (Soft Tissue Injury) 01/2018 - 01/2016
2	Atrophy 02/2016 - 01/2016
1	COVID-19 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Gliosis 01/2018
1	Obesity 01/2018
1	Disease Progression 01/2018
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2016
1	Toxic Optic Neuropathy 01/2016
1	Albinism 01/2016
1	Central Nervous System Diseases (CNS Diseases) 10/2014
1	Chronic Disease (Chronic Diseases) 09/2014
1	Lung Diseases (Lung Disease) 01/2013
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Hypoxia (Hypoxemia) 07/2005

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 01/2018 - 10/2008
7	Complement System Proteins (Complement)IBA 01/2018 - 07/2011
7	Oxygen (Dioxygen)IBA 01/2013 - 07/2005
3	phytobacteriomycin (PBM)IBA 01/2018 - 01/2016
3	ChemokinesIBA 01/2017 - 01/2015
2	Vaccinia virus complement-control proteinIBA 01/2018 - 10/2014
2	RNA (Ribonucleic Acid)IBA 01/2018 - 10/2013
1	TeaIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Complement Inactivating AgentsIBA 01/2018
1	LipidsIBA 01/2018
1	LeptinIBA 01/2018
1	Complement Factor B (Factor B)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	CytokinesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	SodiumIBA 11/2016
1	Pyruvic Acid (Pyruvate)IBA 11/2016
1	cyclo(cysteinyl- glutaminyl- isoleucyl- tryptophyl- lysyl- glutaminyl- lysyl- prolyl- aspartyl- leucyl- cysteinyl- amide)IBA 02/2016
1	Methanol (Carbinol)IBA 01/2016
1	ethylenevinylacetate copolymerIBA 09/2014
1	Acrolein (Aqualin)IBA 10/2013
1	Indicators and Reagents (Reagents)IBA 10/2013
1	Messenger RNA (mRNA)IBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	Dihydrotachysterol (AT 10)IBA 07/2005
1	Ciliary Neurotrophic Factor (CNTF)IBA 05/2005

Therapy/Procedure

4	Low-Level Light Therapy (LLLT) 01/2018 - 06/2011
3	Therapeutics 01/2020 - 01/2013
1	Intravitreal Injections 01/2018
1	Phototherapy (Light Therapy) 12/2017
1	Intraocular Injections 09/2014